Все публикации

0:09:43

Optimizing 1st TAVR to Confer Optimal Durability?Pre vs. Post Dilate? Fracture?- Kendra J. Grubb, MD

0:05:42

Panel Discussion Audience Q&A

0:12:20

So Many Valve Choices: How do Heart Teams Decide Which Valve for Which Patient? - Raj Makkar, MD

0:14:12

Next Rounds of Transcatheter Mitral Trials:Are RCTs Between TEER and TMVR Necessary?Gregg W Stone,MD

0:31:42

Top Ten Advances in Transcatheter Valve Therapy 2023 - Samin K. Sharma, MD

0:11:05

SPOTLIGHT Lecture: Where Will Transcatheter Mitral Interventions be in 2030? - Anita Asgar, MD

0:11:17

Redo-TAVR: An Emerging Epidemic? The Knowns and Unknowns - Vinayak N. Bapat, MD

0:10:43

Selecting Patients for Tricuspid TEER: The Green, Yellow and Red Patients - Anita Asgar, MD

0:41:54

CASE PRESENTATIONS BY STRUCTURAL HEART FELLOWS

0:08:58

Audience Q&A

0:05:22

CONCLUDING REMARKS

0:13:05

Paul Sorajja, MD, How Do We Interpret Tricuspid TEER Trials and Registries

0:15:27

DEBATE: Replacement to Prevail in Transcatheter Tricuspid Interv.-Neil Fam, MD & Howard Herrmann, MD

0:14:41

Advances in Imaging for Tricuspid Valve Intervention: Lessons Learned - Rebecca T Hahn, MD

0:15:40

Robert O Bonow, MD Latest Update on Valvular Heart Disease Strides Made, Looking to the Future

0:11:20

Manish Vinayak, MDT Case Presentation 4

0:11:48

Cesar Soria, MD Case Presentation 1

0:15:59

Gregg W Stone, MD Mitral Valve Intervention Post COAPT Erà

0:09:22

David Gross, MD, PhD Case Presentation 2

0:11:43

Joanna Chikwe, MD FLASH DEBATE Endpoints for Mitral TEER Trials Are Too Soft CON

0:11:58

Cynthia Philip, MD Case Presentation 3

0:12:08

David H Adams, MD FLASH DEBATE Endpoints for Mitral TEER Trials Are Too Soft PRO

0:18:59

Dee Dee Wang, MD KEYNOTE LECTURE Advances in Imaging in Mitral and Tricuspid Valve Intervention

0:12:17

Manish Vinayak, MDT Case Presentation 4